World’s First Gene Therapy Clinical Trial for Glycogen Storage Disease Approved by FDA
April 26, 2018
This week, the U.S. Food and Drug Administration approved the world’s first gene therapy clinical trial for Glycogen Storage Disease (GSD). This ground breaking clinical trial focusing on GSD Type Ia will be hosted by the GSD Program at Connecticut Children’s Medical Center and UConn Health under the direction of leading pediatric endocrinologist and scientist David Weinstein, MD, MMSc.
Connecticut Children’s Medical Center Now One Step Closer Toward Finding a Cure for IBD Thanks to a Seven-Figure Gift to Create First Endowed Chair in Inflammatory Bowel Disease
February 9, 2018
Thanks to an extraordinarily generous seven-figure gift from the Mandell-Braunstein family, the Center for Digestive Diseases at Connecticut Children’s Medical Center has established The Mandell-Braunstein Family Endowed Chair for Pediatric Inflammatory Bowel Disease. The gift will allow the Center for Pediatric Inflammatory Bowel Disease at Connecticut Children’s to expand both its research and clinical treatment efforts, which have already earned the Gastroenterology Division a designation as one of the best in the nation from U.S. News and World Report.
Connecticut Children’s Physician Researcher Drafts Part of the Recently Passed Children’s Health Insurance Program Extension Legislation
February 5, 2018
Connecticut Children’s is proud to announce that our own physician researcher and Chief Research Officer, Glenn Flores, MD, played a direct role in drafting language for the recently passed Children’s Health Insurance Program (CHIP) re-authorization legislation.
Connecticut Children’s Doctor Co-Authors Nationwide Study that Uses Personalized Medicine to Predict Complications in Children Newly Diagnosed with Crohn’s Disease
March 17, 2017
Using a patient’s personal genetic makeup, a team of medical researchers led by a Connecticut Children’s gastroenterologist has discovered a new way to predict if a child newly diagnosed with Crohn’s disease will require major surgery within 3 to 5 years.
Reid R. Sacco Adolescent and Young Adult Cancer Alliance Gift Helps Expand Clinical Trials for Cancer Research at Connecticut Children’s Medical Center
February 22, 2017
A $500,000 gift from the Reid R. Sacco Adolescent and Young Adult (AYA) Cancer Alliance will help Connecticut Children’s Medical Center expand the availability of clinical trials to adolescents and young adults with cancer, a patient population that has not seen as many therapeutic advances in cancer treatment over the past 30 years as compared with younger and older patient populations. The new gift brings the Alliance’s total giving to Connecticut Children’s to $1 million in memory of Gene and Lorraine Saccos’ son, Reid, who died in 2005 at the age of 20, following a two-year battle with sarcoma.